CRISPR THERAPEUTICS AG earnings per share and revenue

CRSP/N earnings per share for the last quarter are -9.17 MXN whereas the estimation was -25.03 MXN which accounts for 63.35% surprise. Company revenue for the same period amounts to 744.14 M MXN despite the estimated figure of 167.94 M MXN. Estimated earnings per share for the next quarter are -25.16 MXN, and revenue is expected to reach 158.10 M MXN. Also watch annual changes over time to get a bigger picture of CRSP/N earnings per share and revenue dynamics.